NDC Number for Lidocaine 23%/Tetracaine 7% Topical Cream
The provided evidence does not contain a specific National Drug Code (NDC) for lidocaine 23%/tetracaine 7% topical cream. The available drug label information only references tetracaine HCL 2% 1 and lidocaine 4% topical products 2, which are different formulations than the requested 23%/7% combination.
What the Evidence Shows
The FDA drug label data provided includes:
- Tetracaine HCL 2% - a single-agent formulation 1
- Lidocaine 4% topical cream - a single-agent formulation 2
Neither of these matches the lidocaine 23%/tetracaine 7% combination product you're asking about.
Clinical Context from Guidelines
While the specific NDC is not available in the evidence, the guidelines do reference lidocaine/tetracaine combination products:
- Lidocaine 7%/Tetracaine 7% cream is mentioned as an FDA-approved self-occlusive topical anesthetic for superficial dermatological procedures 3, 4
- Research demonstrates this 7%/7% formulation is effective for pain reduction during various dermatologic procedures 3, 5
Important Caveat
The concentration you're asking about (lidocaine 23%/tetracaine 7%) appears to be a different formulation than what is commonly referenced in the medical literature. The most frequently cited combination in the evidence is lidocaine 7%/tetracaine 7%, not 23%/7%.
To obtain the specific NDC number for lidocaine 23%/tetracaine 7% cream, you would need to:
- Consult the manufacturer's product labeling directly
- Check the FDA's National Drug Code Directory
- Verify with your pharmacy supplier, as this may be a compounded formulation